证券代码：920476 证券简称：海能技术 公告编号：2026-005 海能未来技术集团股份有限公司 2025 年年度业绩快报公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 特别提示：本公告所载 2025 年年度主要财务数据为初步核算数据，未经会 计师事务所审计，具体数据以公司 2025 年年度报告中披露的数据为准，提请投 资者注意投资风险。 一、2025 年年度主要财务数据和指标 | 项目 | 本报告期 | 上年同期 | 变动比例% | | --- | --- | --- | --- | | 营业收入 | 361,850,165.54 | 310,263,446.74 | 16.63% | | 利润总额 | 43,555,460.24 | 6,032,449.26 | 622.02% | | 归属于上市公司股东的净利润 | 42,117,226.64 | 13,071,710.45 | 222.20% | | 归属于上市公司股东的扣除非 经常性损益的净利润 | 35,570,131.71 | 3 ...

（一）基本情况 根据海能未来技术集团股份有限公司（以下简称"公司"）发展战略及经 营规划，公司拟与铭晔管理咨询（上海）有限公司共同出资设立元神生物医疗 科技（上海）有限公司（暂定名称，以市场监督管理部门核准的名称为准），注 册地位于上海市，注册资本为 200 万元，其中，公司以自有资金出资 20 万元， 持股占比 10%；铭晔管理咨询（上海）有限公司以自有资金出资 180 万元，持 股占比 90%。 证券代码：920476 证券简称：海能技术 公告编号：2026-004 海能未来技术集团股份有限公司 对外投资设立参股公司暨关联交易的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、对外投资概述 参股公司基于光机电技术，拟研究开发用于癌症早期筛查辅助诊断、阿尔 兹海默症诊断等创新型临床医疗器械，并申请医疗器械生产和经营许可。 （二）是否构成重大资产重组 本次交易不构成重大资产重组。 根据《上市公司重大资产重组管理办法》相关规定，公司本次对外投资不 构成重大资产重组。 （三）是否构成关联交易 本次交 ...

每经讯，海能技术2月25日发布公告称，根据海能未来技术集团股份有限公司发展战略及经营规划，公 司拟与铭晔管理咨询（上海）有限公司共同出资设立元神生物医疗科技（上海）有限公司，注册地位于 上海市，注册资本为200万元，其中，公司以自有资金出资20万元，持股占比10%；铭晔管理咨询（上 海）有限公司以自有资金出资180万元，持股占比90%。 （记者 曾健辉） 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每日经济新闻 ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected performance that will exceed the market by over 20% [4]. Core Insights - The company forecasts a significant increase in net profit attributable to shareholders for 2025, estimated between 41 to 44 million yuan, representing a year-on-year growth of approximately 213.65% to 236.61% [1]. - The expected operating revenue for 2025 is around 362 million yuan, reflecting a year-on-year increase of about 16.77% [1]. - The company is actively investing in high-end instruments and has made progress in their smart and digital capabilities, with new products like organic element analyzers and liquid chromatography instruments gaining market recognition [2]. - The company has received multiple invention patents, enhancing its intellectual property moat and supporting future product iterations and market expansion [3]. Financial Summary - The projected financial metrics for the company are as follows: - Operating revenue (million yuan): 341 in 2023, 310 in 2024, 362 in 2025, 435 in 2026, and 499 in 2027, with a year-on-year growth of 18.7% in 2023, -9.1% in 2024, and 16.7% in 2025 [6]. - Net profit attributable to shareholders (million yuan): 45 in 2023, 13 in 2024, 43 in 2025, 53 in 2026, and 64 in 2027, with a year-on-year growth of 1.4% in 2023, -71.0% in 2024, and 225.7% in 2025 [6]. - Earnings per share (EPS): 0.53 in 2023, 0.15 in 2024, 0.50 in 2025, 0.62 in 2026, and 0.75 in 2027 [6]. - Price-to-earnings ratio (P/E): 48.3 in 2023, 166.5 in 2024, 51.1 in 2025, 41.0 in 2026, and 33.9 in 2027 [6].

Investment Rating - The report assigns a "Buy" rating for the company, HaiNeng Technology (920476) [1]. Core Insights - HaiNeng Technology is focusing on the scientific instrument sector, leveraging both self-research and acquisitions to build a diverse product matrix, benefiting from the increasing domestic market share in scientific instruments [3][9]. - The company has established a strong competitive barrier through a full industry chain model, ensuring stable cash flow from its core products while expanding into high-growth areas such as chromatography instruments [3][10]. - The global market for analytical instruments is projected to grow significantly, with China's market expected to reach $11.66 billion by 2029, driven by increasing demand across various sectors [9][53]. Summary by Sections Company Overview - HaiNeng Technology, founded in 2006, specializes in the research, production, and sales of analytical instruments, initially focusing on Kjeldahl nitrogen analyzers and microwave digestion instruments, and later expanding into chromatography instruments [15]. - The company has developed a product matrix that includes organic element analysis, sample preparation, chromatography, and general instruments, serving various industries such as food, pharmaceuticals, and environmental testing [15][9]. Market Potential - The analytical instrument market is characterized by high technical barriers and diverse applications, with significant growth expected in the Chinese market, which is projected to grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2029 [53][50]. - The demand for analytical instruments is widespread across sectors, including food safety, pharmaceuticals, and environmental monitoring, indicating a robust market potential [50][53]. Financial Performance - The company is expected to see a recovery in performance, with projected revenues of 3.79 billion yuan in 2025, reflecting a 22.25% year-on-year growth, and net profits expected to reach 420 million yuan [1][10]. - The earnings per share (EPS) are forecasted to improve from 0.15 yuan in 2024 to 0.49 yuan in 2025, indicating a positive trend in profitability [1][10]. Competitive Landscape - The Chinese analytical instrument market is currently dominated by foreign brands, with a high import rate for advanced products. However, domestic manufacturers like HaiNeng Technology are gradually gaining market share by offering competitive pricing and tailored services [9][58]. - The report highlights the importance of innovation and quality improvement in enhancing the competitive position of domestic firms in the analytical instrument sector [9][58].

Investment Rating - The report assigns a "Buy" rating for the company, HaiNeng Technology (920476) [1]. Core Insights - HaiNeng Technology has established a multi-product matrix through self-research and acquisitions, benefiting from the growth in the scientific instrument sector and increasing domestic market share [3][9]. - The company is focusing on a full industry chain model, which enhances its competitive barriers and ensures stable cash flow from its core products [3][9]. - The market for experimental analysis instruments is expected to grow significantly, with the Chinese market projected to reach $11.66 billion by 2029, driven by increasing domestic demand and a shift towards local production [9][53]. Summary by Sections 1. Company Overview - HaiNeng Technology, founded in 2006, specializes in the research, production, and sales of experimental analysis instruments, initially focusing on Kjeldahl nitrogen analyzers and microwave digestion instruments, and later expanding into chromatography instruments [15]. - The company has developed a diverse product range, including organic element analysis, sample preparation, chromatography, and general instruments, serving various sectors such as food, pharmaceuticals, and environmental testing [15]. 2. Market Potential - The global market for experimental analysis instruments is expected to grow from $82.95 billion in 2024 to $101.58 billion by 2029, with a compound annual growth rate (CAGR) of 4.10% [53][55]. - The Chinese market is anticipated to grow from $9.28 billion in 2024 to $11.66 billion by 2029, with a CAGR of 4.7% [53][55]. 3. Business Strategy - The company employs a multi-brand and multi-product strategy, focusing on high-value and technology-intensive products, particularly in the chromatography sector, which has shown significant growth potential [9][25]. - HaiNeng Technology has made strategic acquisitions to enhance its product offerings and market reach, including investments in companies that possess core technologies [9][15]. 4. Financial Projections - The company is projected to achieve total revenue of 3.79 billion yuan in 2025, with a net profit of 420 million yuan, reflecting a significant recovery in performance driven by increased demand in the pharmaceutical and renewable energy sectors [1][10]. - The earnings per share (EPS) is expected to rise from 0.15 yuan in 2024 to 0.49 yuan in 2025, indicating a strong rebound in profitability [1][10]. 5. Competitive Landscape - The experimental analysis instrument market is characterized by high barriers to entry, with significant competition from established international players, while domestic manufacturers are gradually increasing their market share through improved product quality and customer service [9][58].

Group 1 - The core viewpoint of the news is that Haineng Technology Group Co., Ltd. has released its 2025 performance forecast, indicating a significant increase in net profit compared to the previous year, driven by market demand recovery and growth in various sectors [1] - Haineng Technology expects to achieve a net profit attributable to shareholders of between 41 million to 44 million yuan in 2025, representing a year-on-year increase of 213.65% to 236.61% from 13.07 million yuan in the previous year [1] - The company anticipates a revenue of approximately 362 million yuan in 2025, reflecting a year-on-year growth of about 16.77%, with all product lines expected to contribute to this increase [1] Group 2 - Haineng Technology, established on November 29, 2006, specializes in analytical instruments and solutions for food safety and drug safety supervision, and is recognized as a national-level "little giant" enterprise [2] - As of January 16, 2026, Haineng Technology's stock closed at 24.35 yuan per share, up 2.44%, with a total market capitalization of approximately 2.074 billion yuan [2]

二、对公司的影响 本次对外捐赠是公司积极履行企业社会责任、践行可持续发展理念的实践 举措，资金来源于公司的自有资金，不影响公司正常业务开展及资金使用，对公 司当期及未来经营业绩不构成重大影响，不存在损害公司及中小股东利益的情 形。 特此公告。 证券代码：920476 证券简称：海能技术 公告编号：2026-003 海能未来技术集团股份有限公司 关于对外捐赠的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、对外捐赠事项概述 为支持国家教育事业的发展，海能未来技术集团股份有限公司（以下简称 "公司"）拟以自有资金向天津大学北洋教育发展基金会捐赠现金人民币 30.00 万元，捐赠款项将用于天津大学精密仪器与光电子工程学院曾周末实验室建设 和发展。公司通过本次捐赠，支持曾周末教授科研团队在基于神经网络和深度学 习的智能传感器和智能信号处理方向的研究发展，提升高端仪器产品的智能化 水平，培育支撑高端仪器产业发展的高素质人才。 根据《北京证券交易所股票上市规则》、《公司章程》等相关规定，本次捐赠 事项在董 ...

证券代码：920476 证券简称：海能技术 公告编号：2026-002 海能未来技术集团股份有限公司 第五届董事会第十二次临时会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2026 年 1 月 19 日 2.会议召开地点：山东省德州市临邑县花园东大街 16 号公司会议室 3.会议召开方式：现场结合通讯方式 4.发出董事会会议通知的时间和方式：2026 年 1 月 13 日以电子邮件方式发 出 5.会议主持人：董事长张振方先生 6.会议列席人员：高级管理人员 7.召开情况合法合规的说明： 本次会议的召集、召开、议案审议程序等符合有关法律、行政法规、部门规 章、规范性文件和《公司章程》的规定。 （二）会议出席情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 董事刘文玉、臧恒昌、吕瑞敏、梁锦梅因外地办公原因以通讯方式参与表决。 二、议案审议情况 （一）审议通过《关于对外捐赠的议案》 1.议案内容： 为支持国家教育事业的发展 ...

Investment Rating - The report indicates a positive outlook for the industry, focusing on companies with expected performance improvements and high barriers to entry [2][3]. Core Insights - The report highlights that Lin Tai New Materials anticipates a net profit of 133.3 to 150.7 million yuan for 2025, representing a year-on-year increase of 64.48% to 85.95%, driven by stable sales in traditional automotive and rapid growth in hybrid vehicle components [3][6]. - Hai Neng Technology expects a net profit of 41 to 44 million yuan for 2025, with a significant year-on-year increase of 213.65% to 236.61%, attributed to overall market demand recovery and advancements in high-end instrument manufacturing [3][6]. - The report emphasizes the importance of focusing on companies with strong fundamentals and reasonable valuations, particularly those with expected performance improvements in 2025 [3][6]. Summary by Sections Performance Forecasts - Lin Tai New Materials projects a net profit of 133.3 to 150.7 million yuan for 2025, with growth driven by stable sales in traditional automotive and rapid growth in hybrid vehicle components [3][6]. - Hai Neng Technology forecasts a net profit of 41 to 44 million yuan for 2025, with growth driven by market demand recovery and advancements in high-end instruments [3][6]. Market Trends - The report notes that the North Exchange market is experiencing significant fluctuations, with the North Certificate 50 index declining by 3.6% [3][6]. - The overall PE ratio for North Exchange A shares has risen to 49X, indicating a recovery in market valuations [12][15]. Investment Opportunities - The report suggests focusing on three main areas for investment: companies with expected performance improvements, those related to service consumption, and companies in the new energy vehicle export chain [3][6]. - It highlights the potential for structural investment opportunities within the North Exchange, particularly in specialized and innovative enterprises [3][6].